evenfolioETF Details
ALPS·Health·SBIO · NYSE Arca
ALPS Medical Breakthroughs ETF (SBIO)
- Price
- $54.87
- —30 Oct 2026
- Assets
- $211.6M
- Total net assets
- Expense ratio
- 0.50%
- Category 1.00%
- Yield
- 0.00%
- Trailing distributions
- 1Y return
- 22.8%-6.1%
- Category 28.8%
- 3Y CAGR
- 33.3%+11.8%
- Category 21.5%
- 5Y CAGR
- 4.3%+0.2%
- Category 4.1%
Loading NAV history…
ALPS Medical Breakthroughs ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | -5.9% | -13.4% | +2.5% | +7.1% | +22.8% | +33.3% | +4.3% | +10.4% | +7.7% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | -9.5% | -23.3% | -20.5% | -13.3% | -6.1% | +11.8% | +0.2% | -0.4% | -4.0% |
Holdings
The 10 largest positions make up 30.2% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| CGON | CG Oncology Inc | 3.94% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 3.48% |
| ORKA | Oruka Therapeutics Inc | 3.45% |
| DFTX | Definium Therapeutics Inc Ordinary Shares | 3.20% |
| MANE | Veradermics Inc | 3.17% |
| DNTH | Dianthus Therapeutics Inc | 3.08% |
| EWTX | Edgewise Therapeutics Inc | 2.76% |
| RLAY | Relay Therapeutics Inc Ordinary Shares | 2.48% |
| IDYA | IDEAYA Biosciences Inc | 2.32% |
| AMLX | Amylyx Pharmaceuticals Inc | 2.29% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- —
- P/B
- 3.4
- P/S
- 7.1
- P/CF
- —
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks100.0%
- Cash0.0%
ETF details
- Issuer
- ALPS
- Category
- Equity · Health
- Ticker
- SBIO
- Exchange
- NYSE Arca
- Inception
- 30 Dec 2014 (11.8 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.50% (category 1.00%)
- Holdings turnover
- 58% (category 51%)
- Distribution yield
- 0.00%
- Beta, 3 years
- 0.92
- Total net assets
- $211.6M
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- CANC · Tema Oncology ETFTema ETFs · $208.6M · ER 0.75%
- XHE · State Street SPDR S&P Health Care Equipment ETFState Street Investment Management · $185.7M · ER 0.35%5Y -6.2%
- PSCH · Invesco S&P SmallCap Health Care ETFInvesco · $178.5M · ER 0.29%5Y -1.7%
- BBP · Virtus Biotech ETFVirtus · $131.5M · ER 0.34%5Y 15.0%
- LFSC · F/M Emerald Life Sciences Innovation ETFEmerald Mutual Fund Advisers Trust · $123.4M · ER 0.54%
- IBBQ · Invesco Nasdaq Biotechnology ETFInvesco · $103.3M · ER 0.19%5Y 8.7%